OCSSMALL

Oculis Holding AG

HealthcareBiotechnology
$13.09
$0.01(+9.08%)
52W$10.52
$34.13
Updated Jun 30, 02:00 AM
RSI30
RS Rating6/99
Beta0.88
Volatility64%
F-Score4/9
Mkt Cap$748M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Oculis Holding AG is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 6), showing significant lag compared to the market leaders. Earnings growth of 28% provides fundamental context to the price action. Investors should exercise caution due to high volatility (64% annualized), which requires wider risk management.

Relative Strength
6
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.88
vs S&P 500
DEFENSIVE
52W Position
11%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$21.91
50 SMA > 100 SMA$24.60
100 SMA > 150 SMA$23.78
150 SMA > 200 SMA$22.66

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$11.75+11.38%ABOVE
50 SMA$21.91-40.25%BELOW
100 SMA$24.60-46.78%BELOW
150 SMA$23.78-44.95%BELOW
200 SMA$22.66-42.24%BELOW

Price Performance

1D+9.1%
1W+12.6%
1M-42.3%
3M-46.7%
6M-34.5%
YTD-34.5%
1Y-32.6%
3Y+2.4%
52-Week Trading Range11% from low
$13.09
52W Low$10.52
52W High$34.13

Technical Indicators

RSI (14)OVERSOLD
29.5
305070
Setup ScoreCOOL
5/10
Base depth: 180.4%

Risk Profile

Beta
0.88
52W Vol
64%
ATR
$0.66
Max DD (1Y)
-67%

Volume Analysis

Today
632.4K
50D Avg
767.4K
Vol Ratio
0.82x
Liquidity
MODERATE

Earnings Momentum

Q2'25+4%
$-0.49
Q3'25+33%
$-0.32
Q4'25+39%
$-0.42
Q1'26+28%
$-0.50
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+27.00%

Stock Price CAGR

10 Years:+3.04%
5 Years:+6.09%
3 Years:+2.43%
1 Year:-32.56%

Return on Equity

10Y Avg:-89.2%
5Y Avg:-89.2%
3Y Avg:-89.2%
Last Year:-57.1%

Key Metrics

Market Cap$748M
Gross Margin
Net Margin
Piotroski F-Score4/9

Frequently Asked Questions

Is OCS in an uptrend right now?

OCS has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is OCS overbought or oversold?

OCS's RSI (14) is 30. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.

Is OCS outperforming the market?

OCS has a Relative Strength (RS) Rating of 6 out of 99. OCS is currently lagging the broader market.

Where is OCS in its 52-week range?

OCS is trading at $13.09, which is 38% of its 52-week high ($34.13) and 11% above its 52-week low ($10.52).

How volatile is OCS?

OCS has a Beta of 0.88 and 52-week volatility of 64%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.